1. Home
  2. ADVM vs LRFC Comparison

ADVM vs LRFC Comparison

Compare ADVM & LRFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADVM
  • LRFC
  • Stock Information
  • Founded
  • ADVM 2006
  • LRFC 2013
  • Country
  • ADVM United States
  • LRFC United States
  • Employees
  • ADVM N/A
  • LRFC N/A
  • Industry
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • LRFC Finance: Consumer Services
  • Sector
  • ADVM Health Care
  • LRFC Finance
  • Exchange
  • ADVM Nasdaq
  • LRFC Nasdaq
  • Market Cap
  • ADVM 47.4M
  • LRFC 50.2M
  • IPO Year
  • ADVM 2014
  • LRFC 2013
  • Fundamental
  • Price
  • ADVM $2.39
  • LRFC $18.81
  • Analyst Decision
  • ADVM Strong Buy
  • LRFC
  • Analyst Count
  • ADVM 5
  • LRFC 0
  • Target Price
  • ADVM $23.80
  • LRFC N/A
  • AVG Volume (30 Days)
  • ADVM 338.5K
  • LRFC 11.1K
  • Earning Date
  • ADVM 08-11-2025
  • LRFC 08-07-2025
  • Dividend Yield
  • ADVM N/A
  • LRFC 7.60%
  • EPS Growth
  • ADVM N/A
  • LRFC N/A
  • EPS
  • ADVM N/A
  • LRFC N/A
  • Revenue
  • ADVM $1,000,000.00
  • LRFC $20,544,000.00
  • Revenue This Year
  • ADVM N/A
  • LRFC N/A
  • Revenue Next Year
  • ADVM $18.82
  • LRFC N/A
  • P/E Ratio
  • ADVM N/A
  • LRFC N/A
  • Revenue Growth
  • ADVM N/A
  • LRFC 3.11
  • 52 Week Low
  • ADVM $1.78
  • LRFC $16.57
  • 52 Week High
  • ADVM $10.14
  • LRFC $26.00
  • Technical
  • Relative Strength Index (RSI)
  • ADVM 44.75
  • LRFC 56.96
  • Support Level
  • ADVM $2.11
  • LRFC $18.51
  • Resistance Level
  • ADVM $2.60
  • LRFC $19.06
  • Average True Range (ATR)
  • ADVM 0.22
  • LRFC 0.39
  • MACD
  • ADVM -0.00
  • LRFC 0.12
  • Stochastic Oscillator
  • ADVM 36.39
  • LRFC 84.90

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

About LRFC Logan Ridge Finance Corporation

Logan Ridge Finance Corp an externally managed non-diversified closed-end management investment company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company offers customized financing to business owners, management teams, and financial sponsors for change of ownership transactions, recapitalizations, strategic acquisitions, business expansion, and other growth initiatives.

Share on Social Networks: